Delivery Order SPE2DB22D1017-SPE2DB25FF2XH

Award Date 1/10/25
Potential Completion Date 2/3/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 firm fixed price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.44 delivery order contract is for the supply of BRUKINSA 80 MG CAPSULES 120S, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,484.30 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,492.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4566852339 - BRUKINSA 80 MG CAPSULE 120S and has a completion date of January 29, 2025. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of medical products, including BRUKINSA 80 MG CAPSULE 120S. The award, with a ceiling value of $6,370.00, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a medical product. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2XH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 4/11/25, 11:14 AM